메뉴 건너뛰기




Volumn 2, Issue 1, 2008, Pages 1-3

Business and economics of diabetes

Author keywords

Business; Diabetes; Economics; Product

Indexed keywords


EID: 84887248551     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200101     Document Type: Editorial
Times cited : (1)

References (8)
  • 1
    • 33748447532 scopus 로고    scopus 로고
    • The innovator will prevail in glucose monitoring
    • Green MJ. The innovator will prevail in glucose monitoring. Med Device Technol. 2006;17(4):32-3.
    • (2006) Med Device Technol. , vol.17 , Issue.4 , pp. 32-33
    • Green, M.J.1
  • 2
    • 34147132679 scopus 로고    scopus 로고
    • Information and communications technology in chronic disease care: What are the implications for paymentr?
    • Cronquist Christensen M, Remler D. Information and communications technology in chronic disease care: what are the implications for paymentr? Med Care Res Rev. 2007;64(2):123-47.
    • (2007) Med Care Res Rev. , vol.64 , Issue.2 , pp. 123-147
    • Cronquist Christensen, M.1    Remler, D.2
  • 3
    • 33745023859 scopus 로고    scopus 로고
    • Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes
    • Palmer AJ, Dinneen S, Gavin JR 3rd, Gray A, Herman WH, Karter AJ. Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes. Curr Med Res Opin. 2006;22(5):861-72.
    • (2006) Curr Med Res Opin. , vol.22 , Issue.5 , pp. 861-872
    • Palmer, A.J.1    Dinneen, S.2    Gavin III, J.R.3    Gray, A.4    Herman, W.H.5    Karter, A.J.6
  • 5
    • 34547210808 scopus 로고    scopus 로고
    • Economic impacts attributable to the early clinical benefit of atorvastatin therapy - A US managed care perspective
    • Straka RJ, Mamdani M, Damen J, Kuntze CE, Liu LZ, Botteman MF, Koren MJ. Economic impacts attributable to the early clinical benefit of atorvastatin therapy- A US managed care perspective. Curr Med Res Opin. 2007;23(7):1517-29.
    • (2007) Curr Med Res Opin. , vol.23 , Issue.7 , pp. 1517-1529
    • Straka, R.J.1    Mamdani, M.2    Damen, J.3    Kuntze, C.E.4    Liu, L.Z.5    Botteman, M.F.6    Koren, M.J.7
  • 7
    • 34247588162 scopus 로고    scopus 로고
    • Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control
    • Schmittdiel J, Vijan S, Fireman B, Lafata JE, Oestreicher N, Selby JV. Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control. Med Care. 2007;45(4):315-21.
    • (2007) Med Care. , vol.45 , Issue.4 , pp. 315-321
    • Schmittdiel, J.1    Vijan, S.2    Fireman, B.3    Lafata, J.E.4    Oestreicher, N.5    Selby, J.V.6
  • 8
    • 34250211402 scopus 로고    scopus 로고
    • Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes
    • Millett C, Gray J, Saxena S, Netuveli G, Majeed A. Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes. CMAJ. 2007;176(12):1705-10.
    • (2007) CMAJ. , vol.176 , Issue.12 , pp. 1705-1710
    • Millett, C.1    Gray, J.2    Saxena, S.3    Netuveli, G.4    Majeed, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.